Bacteria-triggered CD4+ T regulatory cells suppress Helicobacter hepaticus-induced colitis

Journal of Experimental Medicine

Volumn 196, Issue 4, 2002, Pages 505-515

  Kullberg, Marika C ^a   Jankovic, Dragana ^a   Gorelick, Peter L ^c   Caspar, Patricia ^a   Letterio, John J ^b   Cheever, Allen W ^d   Sher, Alan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

CD25; Immunoregulation; Inflammatory bowel disease; Intestinal flora; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER HEPATICUS; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INTESTINE FLORA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD45; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DNA-BINDING PROTEINS; FEMALE; HELICOBACTER; HELICOBACTER INFECTIONS; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037136284     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020556     Document Type: Article

References (50)

1. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
2. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats
3. T cell receptor-αβ-deficient mice fail to develop colitis in the absence of a microbial environment
4. IL-2-deficient mice raised under germ-free conditions develop delayed mild focal intestinal inflammation
5. + TH1-like responses
6. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
7. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice
8. + T cells
9. + T-cells in the regulation of inflammatory responses in the intestine
10. high T cells to SCID recipients
11. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment
12. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases
13. Review-antibiotic treatment in inflammatory bowel disease: Rifaximin, a new possible approach
14. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?
15. + T cells are important for the balance between protective and pathogenic cell-mediated immunity
16. + T cells
17. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
18. + regulatory cells that control intestinal inflammation
19. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10
20. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism
21. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: Cytokine requirements for the induction and maintenance of intestinal inflammation
22. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
23. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis
24. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines
25. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species
26. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice
27. + T cells: A population of T cells with immune regulatory activities in vitro
28. + lymphocytes with a Th2 cytokine profile
29. low subset
30. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
31. Autoiimmune disease as a consequence of developmental abnormality of a T cell subpopulation
32. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
33. + immunoregulatory T cells that control autoimmune diabetes
34. - subpopulations
35. + regulatory T cells induced by an agonist self-peptide
36. + immunoregulatory T cells
37. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity
38. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis
39. Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus
40. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
41. Murine ileitis after intracellular parasite infection is controlled by TGF-β-producing intraepithelial lymphocytes
42. Control of intestinal inflammation by regulatory T cells
43. + immunoregulatory T cells is antigen nonspecific
44. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
45. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
46. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice
47. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
48. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
49. + T cell down-regulation in human intestinal mucosa: Evidence for intestinal tolerance to luminal bacterial antigens